Brief: Ascentage Pharma Announces Pricing Of U.S. Initial Public Offering
Jan 23 (Reuters) - Ascentage Pharma Group International
6855.HK :
* ASCENTAGE PHARMA ANNOUNCES PRICING OF U.S. INITIAL PUBLIC
OFFERING
* ASCENTAGE PHARMA GROUP INTERNATIONAL: PRICING OF ITS U.S.
INITIAL PUBLIC OFFERING OF 7,325,000 ADS, AT A PUBLIC OFFERING
PRICE OF $17.25 PER ADS
* ASCENTAGE PHARMA GROUP INTERNATIONAL: TO BEGIN TRADING ON
NASDAQ
UNDER TICKER SYMBOL "AAPG" FOR "REGULAR-WAY" TRADING
Source text: ID:nGNXc0PCND
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up